Multiple myeloma, version 1.2020: Featured updates to the NCCN guidelines Guidelines


Authors: Kumar, S. K.; Callander, N. S.; Hillengass, J.; Liedtke, M.; Baljevic, M.; Campagnaro, E.; Castillo, J. J.; Chandler, J. C.; Cornell, R. F.; Costello, C.; Efebera, Y.; Faiman, M.; Garfall, A.; Godby, K.; Holmberg, L.; Htut, M.; Huff, C. A.; Kang, Y.; Landgren, O.; Malek, E.; Martin, T.; Omel, J.; Raje, N.; Sborov, D.; Singhal, S.; Stockerl-Goldstein, K.; Tan, C.; Weber, D.; Johnson-Chilla, A.; Keller, J.; Kumar, R.
Title: Multiple myeloma, version 1.2020: Featured updates to the NCCN guidelines
Abstract: The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 17
Issue: 10
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2019-10-01
Start Page: 1154
End Page: 1165
Language: English
DOI: 10.6004/jnccn.2019.0049
PUBMED: 31590151
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carl Ola Landgren
    336 Landgren
Related MSK Work